Tag: CBT > Biden Cannabis Policy: Page 4

Interviews & Opinion

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

August 29, 2023

Cannabis Rescheduling

New Coalition Launches Campaign in Support of Cannabis Scheduling Reform

As the Biden Administration actively reviews the classification of cannabis under the Controlled Substances Act, a diverse group of cannabis companies and organizations is partnering with scientific and legal experts to launch the Coalition for Cannabis Scheduling Reform.

June 6, 2023

Cannabis Rescheduling

Helpful, or Yet Another Hurdle?

Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.

December 23, 2022

2022 Election and Cannabis Legalization Ballot Measures

Recent Cannabis Policy Reform at a Glance

December 23, 2022

Interviews & Opinion

What’s Next for the Cannabis Industry Following the Midterm Elections?

Cannabis-focused attorneys share their predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift heading into next year.

November 18, 2022

Legislation and Regulation

Witnesses Stress Need For Cannabis Descheduling, Uniform Regulation at US House Hearing on Federal Reform

Cannabis advocates say that through federal reform, the U.S. government can work to ensure a thriving industry, social equity and justice in communities of color, treatment for veterans with PTSD and more while reducing the illicit market.

November 15, 2022

Legislation and Regulation

US House Members Release Memo on Benefits of Cannabis Decriminalization, Descheduling, Propose Reforms

The U.S. House Oversight Committee’s Subcommittee on Civil Rights and Civil Liberties released the joint memo ahead of a Nov. 15 hearing on cannabis.

November 14, 2022

Legislation and Regulation

Global Alliance for Cannabis Commerce Discusses Federal and State Cannabis Policy Ahead of Congressional Hearing Testimony

GACC leaders Randal John Meyer and Rezwan Khan broke down some of the industry trade group’s approaches and positions on state and federal reform.

November 14, 2022

Legislation and Regulation

Cannabis Operators Reflect on Biden’s Pardons

Plant-touching operators across the industry applaud the president’s calls for reform, but insist more must be done.

November 14, 2022

Legislation and Regulation

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

November 7, 2022

Industry Headlines

Sentencing Commission Estimates More Than 6,500 Americans Are Eligible to Receive Pardons Under President’s Federal Cannabis Policy Reform Plan

The USSC’s analysis includes federal data dating back to 1992.

October 28, 2022

Legislation and Regulation

Biden's Order to Review Cannabis 'Truly Historic,' But What's at Stake?

Many industry experts agree removing cannabis from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster' for the state-legal industry.

October 26, 2022